Emergent Health Corp
EMGE · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $0 | $0 |
| % Growth | 184.5% | 380.6% | -28.5% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 63.5% | 22.2% | 49.7% | 72.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $0 | $0 |
| Operating Income | -$1 | -$2 | -$0 | -$0 |
| % Margin | -86.1% | -305.6% | -166.9% | -47.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$2 | -$2 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$0 | -$0 |
| % Margin | -99.6% | -366.8% | -241.5% | -47.3% |
| EPS | -0.004 | -0.008 | -0.005 | -0.001 |
| % Growth | 50.6% | -62% | -257.1% | – |
| EPS Diluted | -0.004 | -0.008 | -0.005 | -0.001 |
| Weighted Avg Shares Out | 403 | 261 | 58 | 58 |
| Weighted Avg Shares Out Dil | 403 | 261 | 58 | 57 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$0 | -$0 |
| % Margin | -84.9% | -300.6% | -150.2% | -33.5% |